DENARASE® is now directly available at c-LEcta. c-LEcta has taken over the product distribution from Sartorius Stedim Biotech GmbH by the end of 2016 and now sells DENARASE® under the same brand name and in identical package sizes. Furthermore, c-LEcta continues to produce the endonuclease in the same production facilities using its patent protected production process in full compliance with cGMP requirements. This process allows to provide DENARASE® in an outstanding product quality and at low prices.
DENARASE® from Serratia marcenses is a highly active nuclease that is used to remove interfering DNA and RNA from fermentation batches e.g. during the production of vaccines and biopharmaceuticals.
The advantages of DENARASE® are:
+ Animal product free production
+ endotoxin-free production strain
+ high purity and activity
+ compliance with cGMP
If you are interested in testing our DENARASE or if you need further information, please do not hesitate to contact c-LEcta GmbH via email@example.com.